Skip to main content
Journal cover image

Durability of responses in patients with metastatic renal cell carcinoma treated with high dose lnterleukin-2 (HD IL-2)

Publication ,  Conference
Clark, JI; Morse, MA; Wong, MKK; Mcdermott, DF; Kaufman, HL; Daniels, GA; Perritt, JC; Hua, H; Aung, S
Published in: BJU INTERNATIONAL
December 1, 2015

Duke Scholars

Published In

BJU INTERNATIONAL

EISSN

1464-410X

ISSN

1464-4096

Publication Date

December 1, 2015

Volume

116

Start / End Page

6 / 6

Location

Miami, FL

Publisher

WILEY-BLACKWELL

Conference Name

14th International Kidney Cancer Symposium

Related Subject Headings

  • Urology & Nephrology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Clark, J. I., Morse, M. A., Wong, M. K. K., Mcdermott, D. F., Kaufman, H. L., Daniels, G. A., … Aung, S. (2015). Durability of responses in patients with metastatic renal cell carcinoma treated with high dose lnterleukin-2 (HD IL-2). In BJU INTERNATIONAL (Vol. 116, pp. 6–6). Miami, FL: WILEY-BLACKWELL.
Clark, Joseph I., Michael A. Morse, Michael K. K. Wong, David F. Mcdermott, Howard L. Kaufman, Gregory A. Daniels, Jessica C. Perritt, Hong Hua, and Sandra Aung. “Durability of responses in patients with metastatic renal cell carcinoma treated with high dose lnterleukin-2 (HD IL-2).” In BJU INTERNATIONAL, 116:6–6. WILEY-BLACKWELL, 2015.
Clark JI, Morse MA, Wong MKK, Mcdermott DF, Kaufman HL, Daniels GA, et al. Durability of responses in patients with metastatic renal cell carcinoma treated with high dose lnterleukin-2 (HD IL-2). In: BJU INTERNATIONAL. WILEY-BLACKWELL; 2015. p. 6–6.
Clark, Joseph I., et al. “Durability of responses in patients with metastatic renal cell carcinoma treated with high dose lnterleukin-2 (HD IL-2).” BJU INTERNATIONAL, vol. 116, WILEY-BLACKWELL, 2015, pp. 6–6.
Clark JI, Morse MA, Wong MKK, Mcdermott DF, Kaufman HL, Daniels GA, Perritt JC, Hua H, Aung S. Durability of responses in patients with metastatic renal cell carcinoma treated with high dose lnterleukin-2 (HD IL-2). BJU INTERNATIONAL. WILEY-BLACKWELL; 2015. p. 6–6.
Journal cover image

Published In

BJU INTERNATIONAL

EISSN

1464-410X

ISSN

1464-4096

Publication Date

December 1, 2015

Volume

116

Start / End Page

6 / 6

Location

Miami, FL

Publisher

WILEY-BLACKWELL

Conference Name

14th International Kidney Cancer Symposium

Related Subject Headings

  • Urology & Nephrology
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1103 Clinical Sciences